IMM Immupharma Plc

TIDMIMM

RNS Number : 3973M

Immupharma PLC

06 May 2015

 
    6 MAY 2015 
 

ImmuPharma

ANNUAL REPORT AND ACCOUNTS

NOTICE OF ANNUAL GENERAL MEETING: 29 MAY 2015

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2014 will be posted to shareholders today.

The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Friday 29 May 2015 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

For further information please contact:

 
                                               + 44 (0) 20 
 ImmuPharma plc                                  7152 4080 
 Dimitri Dimitriou, Chief Executive 
  Officer 
 Dr Robert Zimmer, President and 
  Chief Scientific Officer 
 Franco di Muzio, Interim Chairman 
 Tracy Weimar, Vice President, Operations 
  and Finance 
 Lisa Baderoon, Head of Investor             + 44 (0) 7721 
  Relations                                         413496 
 
 Panmure Gordon (UK) Limited, NOMAD             +44 (0) 20 
  & Broker                                       7886 2500 
 Hugh Morgan, Fred Walsh, Duncan 
  Monteith, Corporate Finance 
  Charles Leigh-Pemberton, Corporate 
  Broking 
 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSUGUPCAUPAGCQ

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024